Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-07 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-06 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-06 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |